Webinars
June 6, 2024 | 12:00 - 12:45 PM ET
Two additional sessions will be offered: June 11, 2024 | 16:00 – 16:45 (UTC+8:00) – Asia/ShanghaiJune 11, 2024 | 15:00 – 15:45 CET – Europe/Berlin
Join us for the next webinar in our “Making AI Real” webinar series, where we will focus on practical applications of generative AI for Medical Affairs.Medical Affairs teams are rapidly adopting generative AI to work more efficiently and effectively, although key challenges have begun to emerge. In this webinar, we will explore the best use…
Sign Up Now
Webinars
June 13, 2024 | 1:00 - 1:45 PM ET
An additional session will be offered on June 18, 2024 at 15:00 – 15:45 CET – Europe/Berlin
A number of critical manufacturer activities are informed by understanding health technology assessment (HTA) agency behavior across geographies and therapeutic areas—from pipeline, business development and licensing to launch planning preparation through to lifecycle management strategy. Join Max Hunt, a Partner in Trinity Life Sciences’ Evidence, Value, Access & Pricing Practice, as he hosts a lively discussion on the benefits of rapid access to…
Sign Up Now
White Papers
To date, life sciences’ efforts towards driving equitable healthcare have centered around access to care, early identification and prevention. Meanwhile, less attention has been given to the impact of the racial and ethnic homogeneity in trial populations. Clinical trial diversity continues to be one of the greatest challenges pharmaceutical and biotech companies face in ensuring the delivery of medicines that are effective for all people. Diverse clinical trial populations are an integral step in achieving equitable healthcare treatment.
While we…
Read Now
Blog
Published April 30, 2024
Reliable forecast models are a cornerstone of any successful commercialization plan.
The inputs that drive those forecast models are critical.
From 2020 through 2022:
Only
1
in
10
products had performance aligned with forecasted expectations*
Nearly
60% underperformed their forecast expectations
More than
30% overperformed
Forecast models often rely on healthcare professional (HCP)-reported behavioral data.
Various subjective calibration factors are required to render the data usable, even after implementing robust market research design elements.
Data from primary market research (PMR)…
Read Now
Webinars
May 30, 2024 | 1:00 - 1:45 PM ET
Two additional sessions will be offered: June 4, 2024 | 16:00 – 16:45 (UTC+8:00) – Asia/ShanghaiJune 4, 2024 | 15:00 – 15:45 CET – Europe/Berlin
Did you know 62% of products launched between September 2019 and December 2021 underperformed expectations in the first year of launch?
What is going wrong, and how can we get it right? Join Trinity Life Sciences for a thought-provoking webinar to dive into the first white paper in our Industry Impact Series, Picking Winners: Portfolio Management for…
Sign Up Now
Blog
Published April 22, 2024
Executive Summary
The latest publication of new reimbursement regulations in the French Social Security Financing Act (PLFSS 2024), coupled with the recent approval of HEMGENIX® through the direct access scheme in France this past December, underline continued efforts in France to innovate its healthcare system.
The 2024 PLFSS emphasizes:
Drug access and cost containment, with a higher payback trigger aimed at reducing the government’s payback collections
Temporary reimbursement to ensure continuous treatment of patients with medicines benefitting from the early…
Read Now
Scientific Publications
Healthcare Resource Utilization of Patients with Short Bowel Syndrome Dependent on Parenteral Support: A Retrospective Claims Analysis
AUTHOR(S): Ali A1, Micic D2, Gallivan M1, Kulkarni A3, Henderson J4, Mitchell G4 1Trinity Life Sciences, Waltham, MA, USA, 2University of Chicago Medical Center, Gastroenterology, Hepatology, and Nutrition, Chicago, IL, USA, 3Trinity Life Sciences, Malden, MA, USA, 4VectivBio AG, Basel, Basel, Switzerland
OBJECTIVES: Short bowel syndrome with intestinal failure (SBS-IF) is a rare, chronic, debilitating malabsorptive condition often caused by massive resection of the…
Read Now
Webinars
Available On Demand
Generative AI (GenAI) has created an opportunity to re-think and significantly improve how we work. Although far from replacing humans, GenAI has the potential to make pharma professionals far more effective and valuable to their organizations. Join us for “Making AI Real,” a webinar series from Trinity Life Sciences dedicated to exploring how to leverage generative AI across different areas within pharmaceutical commercial operations and medical affairs. Our first webinar in this series will be on AI for Insights: discover how generative AI…
Watch Now
Webinars
Available On Demand
How can manufacturers strategize for pricing and market access success amidst the evolving landscape of China’s NRDL?
As China continues to be a key pharmaceutical market, understanding the latest National Reimbursement Drug List (NRDL) trends and policy evolvement is crucial for manufacturers aiming to achieve successful access and pricing outcomes.
In this webinar, a panel of Trinity Life Sciences’ Value, Access and Pricing experts will discuss the role of the new value-based assessment framework in NRDL payer decision-making and dive…
Watch Now
White Papers
Since the passage of the Inflation Reduction Act (IRA) in 2022, the pharmaceutical industry has significantly altered how they approach and plan for evidence generation activities to best support product launches and pricing and access negotiations. Leading life science companies are taking proactive steps to adjust how and when they develop evidence and how they deploy it to better support their innovative medicines at launch and beyond.
Complete the form below to access the full white paper
By submitting this…
Read Now